Miopatia inflamatória induzida por adalimumab na artrite reumatóide

The application of immunobiologics for the rheu­matoid arthritis treatment may present as a rare complication the development of inflammatory myopathy. Until this moment, there have been des­cribed in literature only seven cases of inhibitors of tumor necrosis factor induced-myositis. In this paper, we report the case of the patient with 39 years--old with eight years of arthritis rheumatoid and that due to refractory to various immunosuppressive drugs, the adalimumab was introduced, and e­volved to dermatomyositis status.